Enhanced binding of NF-κB and HIF-1α to the CXCR4 promoter upregulates the expression of CXCR4, which facilitates the migration and invasion of gemcitabine-treated PC cells and mediates acquired gemcitabine resistance [220]. This evidence concerns the gene CXCR4 and pachyonychia congenita.